GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Dexamethasone Tablets BP 0.75mg
C. Dexamethasone Tablets BP 2mg
D. Dexamethasone Tablets BP 4mg
E. Dexamethasone Tablets BP 6mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each uncoated tablets contains:
Dexamethasone BP……………….0.5mg
Excipients………………. q. s
B. Dexamethasone Tablets BP 0.75mg
Each uncoated tablets contains:
Dexamethasone BP……………….0.75mg
Excipients………………. q. s
C. Dexamethasone Tablets BP 2mg
Each uncoated tablets contains:
Dexamethasone BP……………….2mg
Excipients………………. q. s
D. Dexamethasone Tablets BP 4mg
Each uncoated tablets contains:
Dexamethasone BP……………….4mg
Excipients………………. q. s
E. Dexamethasone Tablets BP 6mg
Each uncoated tablets contains:
Dexamethasone BP……………….6mg
Excipients………………. q. s
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
Gluten-free
Read enclosed leaflet before use.
WARNING: TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
STORAGE & DOSAGE:
Keep in a cool & dry place.
Protected from light & moisture.
Dosage: As directed by the Physician.
Attach dispensing label as per end country.
Dexamethasone Tablets BP 0.5mg Technical Specification:
| Product Name: | Dexamethasone Tablets BP 0.5mg |
| Brand Name: | Generic |
| Strength: | 0.5mg, 0.75mg, 2mg, 4mg, 6mg |
| Dosage Form: | Tablets (uncoated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Corticosteroids |
| Indication: | Dexamethasone Tablets relieves inflammation (swelling, heat, redness, and pain) and is used to treat certain forms of arthritis; skin, blood, kidney, eye, thyroid, and intestinal disorders (e.g., colitis); severe allergies; and asthma. |
| Storage: | Store at a temperature not exceeding 25°C. Keep in a cool & dry place. Protected from light & moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Dexamethasone Tablets BP 0.5mg
- Dexamethasone Tablets BP 0.75mg
- Dexamethasone Tablets BP 2mg
- Dexamethasone Tablets BP 4mg
- Dexamethasone Tablets BP 6mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Dexamethasone Tablets BP 0.5mg
Each uncoated tablets contains:
Dexamethasone BP……………….0.5mg
Excipients………………. q. s - Dexamethasone Tablets BP 0.75mg
Each uncoated tablets contains:
Dexamethasone BP……………….0.75mg
Excipients………………. q. s - Dexamethasone Tablets BP 2mg
Each uncoated tablets contains:
Dexamethasone BP……………….2mg
Excipients………………. q. s - Dexamethasone Tablets BP 4mg
Each uncoated tablets contains:
Dexamethasone BP……………….4mg
Excipients………………. q. s - Dexamethasone Tablets BP 6mg
Each uncoated tablets contains:
Dexamethasone BP……………….6mg
Excipients………………. q. s
THERAPEUTIC INDICATIONS:
Dexamethasone Tablets relieves inflammation (swelling, heat, redness, and pain) and is used to treat certain forms of arthritis; skin, blood, kidney, eye, thyroid, and intestinal disorders (e.g., colitis); severe allergies; and asthma.
CAUTION & WARNING:
CAUTION: SWALLOW WHOLE DO NOT CHEW OR CRUSH.
Gluten-free
Read enclosed leaflet before use.
WARNING: TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER ONLY.
Keep medicine out of reach of children.
STORAGE & DOSAGE:
Storage: Store at a temperature not exceeding 25°C. Keep in a cool & dry place. Protected from light & moisture.
Dosage: As directed by the Physician.
Attach dispensing label as per end country.
Dexamethasone Tablets BP 0.5mg Manufacturer in India
Introduction to Dexamethasone Tablets BP 0.5mg
Dexamethasone Tablets BP 0.5mg are an oral corticosteroid formulation containing dexamethasone, a potent synthetic glucocorticoid used in a range of inflammatory, allergic, immune-mediated, and other medical conditions where corticosteroid therapy is considered appropriate. The medicine works primarily by modifying inflammatory and immune responses, thereby helping reduce symptoms associated with inflammation, swelling, and excessive immune activity.
Taj Pharma Ltd is a pharmaceutical manufacturer, exporter, and supplier based in Vapi, Gujarat, India, offering Dexamethasone Tablets BP 0.5mg for pharmaceutical distribution and international supply, subject to applicable regulatory and commercial requirements. The product is manufactured as a tablet dosage form and can be supplied according to approved product specifications, packaging requirements, and destination-market regulations.
Dexamethasone has an established role across several therapeutic areas because of its strong glucocorticoid activity. Depending on the approved indication and local prescribing information, dexamethasone may be used for selected inflammatory conditions, allergic disorders, autoimmune and immune-mediated diseases, certain hematological conditions, cerebral edema, and specific oncology-related indications. Its use should always be guided by an appropriately qualified healthcare professional.
Global demand for corticosteroid medicines remains significant because healthcare systems require reliable access to products used for inflammatory and immune-mediated conditions. For international buyers, wholesalers, distributors, hospitals, and pharmaceutical companies, consistent manufacturing quality, regulatory documentation, packaging flexibility, and dependable supply are important considerations when sourcing Dexamethasone Tablets BP 0.5mg from India.
What Are Dexamethasone Tablets BP 0.5mg?
Dexamethasone Tablets BP 0.5mg contain dexamethasone in a 0.5mg strength in tablet form. “BP” refers to the British Pharmacopoeia standard where applicable to the product specification. The finished product should be manufactured and tested according to the approved specifications applicable to the intended market.
Dexamethasone belongs to the glucocorticoid corticosteroid class. Unlike medicines that directly eliminate infectious organisms, corticosteroids primarily work by suppressing or regulating inflammatory and immune responses. This makes dexamethasone useful in selected conditions in which inflammation or excessive immune activity contributes significantly to disease symptoms.
Because dexamethasone is a potent corticosteroid, the appropriate dose and treatment duration can vary considerably according to the medical condition, patient characteristics, and clinical response. Dexamethasone should not be self-medicated or discontinued abruptly after prolonged treatment without medical advice.
Uses and Therapeutic Applications of Dexamethasone Tablets BP 0.5mg
Dexamethasone may be prescribed for a variety of conditions involving inflammation, immune activity, or corticosteroid-responsive disease processes. The exact approved uses vary between countries and product registrations.
Depending on the clinical indication, dexamethasone may be used in the management of selected inflammatory disorders, allergic conditions, autoimmune or immune-mediated diseases, certain skin disorders, respiratory inflammatory conditions, rheumatic disorders, and other corticosteroid-responsive conditions.
It may also have applications in specific hospital and specialist settings, including certain oncology-related conditions and cerebral edema, when clinically appropriate.
The medicine is not intended to treat every cause of swelling, pain, redness, or itching. In particular, corticosteroids can suppress immune responses and may worsen or mask certain infections. Therefore, the underlying diagnosis and the benefit-risk profile should be assessed before treatment.
How Does Dexamethasone Work?
Dexamethasone produces its effects primarily through interaction with glucocorticoid receptors inside cells. After entering cells, the drug influences gene transcription and modifies the production of numerous proteins involved in inflammatory and immune processes.
Through these actions, dexamethasone can reduce the production or activity of various inflammatory mediators. This helps decrease inflammation, swelling, immune-system activation, and other corticosteroid-responsive symptoms.
Its potent anti-inflammatory and immunosuppressive properties explain why dexamethasone has applications across multiple therapeutic specialties. However, these same properties mean that prolonged or inappropriate use can produce clinically significant adverse effects.
Potential Therapeutic Benefits
When prescribed for an appropriate indication, Dexamethasone Tablets BP 0.5mg may provide clinically useful corticosteroid activity by reducing excessive inflammation and modifying abnormal immune responses.
Potential therapeutic benefits include reduction of inflammatory swelling, allergic-type symptoms, immune-mediated inflammation, and other manifestations associated with corticosteroid-responsive conditions.
The benefits depend on the underlying disease, prescribed dose, treatment duration, and individual patient response. Dexamethasone is a prescription corticosteroid and should therefore be used according to the approved prescribing information and healthcare-professional guidance.
Dexamethasone Tablets BP 0.5mg Manufacturer in India
Taj Pharma Ltd is a pharmaceutical company based in Vapi, Gujarat, India, involved in the manufacture, supply, and export of pharmaceutical products. The company supports pharmaceutical buyers and distribution partners seeking finished dosage forms from India.
For Dexamethasone Tablets BP 0.5mg, manufacturing and quality-control activities should be performed according to the applicable approved specifications, manufacturing procedures, testing requirements, and regulatory standards for the intended market.
For institutional buyers, importers, distributors, and pharmaceutical companies, sourcing from an experienced Indian pharmaceutical supplier can support procurement requirements involving batch consistency, documentation, packaging coordination, commercial supply, and export logistics.
Dexamethasone Tablets BP 0.5mg Supplier from India
As a Dexamethasone Tablets BP 0.5mg supplier in India, Taj Pharma can support B2B pharmaceutical procurement requirements for eligible customers and markets.
International buyers may require product information, specifications, packaging details, certificates, shipping documentation, and other regulatory records before placing commercial orders. Documentation supplied for a particular product should correspond to the actual product, manufacturing site, batch, and destination-market requirements.
The availability of particular pack sizes, minimum order quantities, artwork, private-label arrangements, and export documentation can be discussed according to the buyer’s requirements and applicable regulations.
Dexamethasone Tablets BP 0.5mg Exporter from India
India is an established pharmaceutical manufacturing and export hub, with pharmaceutical companies supplying finished formulations to numerous international markets.
Taj Pharma supports pharmaceutical export from India by coordinating product supply, documentation, packaging requirements, and commercial communication with international customers, subject to applicable laws and destination-country requirements.
For buyers looking for a Dexamethasone Tablets BP 0.5mg exporter from India, important considerations include product registration status, import permissions, labeling requirements, quality documentation, shipping conditions, and the regulatory status of corticosteroid products in the destination market.
Regulatory Documentation for Importers, Exporters & Buyers
International pharmaceutical buyers often require a comprehensive documentation package before importing a medicinal product. The precise documentation depends on the product, country, registration pathway, and regulatory authority.
Depending on the transaction and destination market, relevant documentation may include:
- Certificate of Analysis (CoA)
- Product specification
- Finished-product test reports
- Batch manufacturing documentation, where applicable
- Packaging and labeling information
- Certificate of Pharmaceutical Product (CPP/COPP), where applicable
- Manufacturing-site documentation
- Stability-related documentation, where applicable
- Product registration documents
- Drug license or manufacturing authorization documentation
- GMP-related documentation where applicable
- Safety and technical product information
- Shipping and commercial documentation
- Other documents requested by the importing authority
Regulatory documentation should be provided according to the actual regulatory status of the product and manufacturing facility. Buyers should verify which documents are mandatory for their particular market before finalizing registration or import procedures.
Custom Packaging & Labeling
Pharmaceutical buyers frequently require packaging adapted to local regulatory and commercial requirements. Custom packaging and labeling may be considered where permitted by the approved product registration and applicable regulations.
Packaging specifications may include:
- Blister or strip presentation
- Carton configuration
- Batch number
- Manufacturing date
- Expiry date
- Storage instructions
- Product composition
- Manufacturing details
- Regulatory information
- Country-specific labeling
- Barcode or serialization requirements, where applicable
Any private-label or contract-packaging arrangement must comply with the applicable regulatory framework. Artwork should be reviewed and approved before commercial production.
Shelf Life, Storage & Dosage Form
Dexamethasone Tablets BP 0.5mg are supplied as an oral tablet dosage form containing 0.5mg dexamethasone per tablet, according to the approved product specification.
The product should be stored according to the approved product labeling and stability requirements. Buyers should follow the storage conditions specified on the actual commercial pack rather than relying on generalized storage assumptions.
The exact shelf life should be stated according to the approved product specification and supporting stability data for the applicable product and market.
Dosage Form
- Dosage Form: Tablets
- Strength: 0.5mg
- Route: Oral
- Active Ingredient: Dexamethasone
- Pharmacological Class: Glucocorticoid corticosteroid
Patients should take the medicine exactly as prescribed. Where appropriate, taking corticosteroid tablets with food may help reduce stomach irritation, but the patient should follow the specific prescribing instructions provided by their healthcare professional.
Export Certifications: WHO-GMP, EU-GMP, COPP & CTD Dossier
For pharmaceutical exports, regulatory requirements differ substantially between markets. Buyers may request documents such as GMP evidence, CPP/COPP, CTD documentation, product dossiers, certificates of analysis, manufacturing licenses, and other technical records.
WHO-GMP
The phrase WHO-GMP manufacturer in India should only be used where the relevant manufacturing facility holds an applicable and current GMP certification covering the relevant operations. Certification status, scope, and validity should be verified for the specific facility and product.
EU-GMP
EU-GMP requirements may apply when supplying pharmaceutical products to European markets or other jurisdictions that recognize or require equivalent standards. The applicable authorization depends on the manufacturing facility, product, and regulatory pathway.
COPP / CPP
A Certificate of Pharmaceutical Product (CPP/COPP) may be required by certain importing authorities as part of a pharmaceutical registration or import process. Availability depends on the applicable regulatory framework and product status.
CTD Dossier
A Common Technical Document (CTD) or equivalent product dossier may be required for registration in certain markets. It generally organizes pharmaceutical quality, safety, and efficacy information into a standardized regulatory structure.
Taj Pharma can discuss applicable documentation requirements with prospective buyers based on the destination country, product registration pathway, and commercial requirements.
Target Countries & Export Markets
Pharmaceutical export requirements vary by jurisdiction. Dexamethasone products are subject to local registration, prescription, import, labeling, and regulatory controls, which should be evaluated before shipment.
Taj Pharma can support inquiries relating to international pharmaceutical supply in markets such as:
- United States | United Kingdom | Germany | France | Italy | Spain | Canada | United Arab Emirates | Saudi Arabia | South Africa | Nigeria | Kenya | Brazil | Mexico | Argentina | Russia | Vietnam | Thailand | Indonesia | Philippines
The ability to supply a specific market depends on product registration, import authorization, regulatory approval, commercial feasibility, and applicable pharmaceutical laws in the destination country.
Why Choose Taj Pharma for Dexamethasone Tablets BP 0.5mg?
State-of-the-Art Manufacturing Approach
Reliable pharmaceutical manufacturing requires controlled production processes, documented procedures, qualified personnel, appropriate testing, and consistent quality systems. Taj Pharma focuses on supporting pharmaceutical customers through structured manufacturing and supply processes appropriate to the applicable product requirements.
Affordable Pricing & Quality Assurance
For pharmaceutical importers and distributors, procurement decisions often depend on a combination of quality, commercial competitiveness, documentation, supply continuity, and packaging requirements.
Taj Pharma aims to provide commercially competitive pharmaceutical solutions while maintaining product specifications and quality requirements applicable to the supplied formulation.
Global Presence & Supply Chain Support
International pharmaceutical supply involves more than manufacturing. Buyers may need assistance with commercial documentation, packaging coordination, regulatory documents, logistics communication, and export planning.
Taj Pharma supports international customers through a coordinated pharmaceutical supply-chain approach.
20 Countries Exporting
United States | United Kingdom | Germany | France | Italy | Spain | Canada | United Arab Emirates | Saudi Arabia | South Africa | Nigeria | Kenya | Brazil | Mexico | Argentina | Russia | Vietnam | Thailand | Indonesia | Philippines
Technical Product Specification
| Product Parameter | Specification |
|---|---|
| Product Name | Dexamethasone Tablets BP 0.5mg |
| Active Ingredient | Dexamethasone |
| Strength | 0.5mg |
| Dosage Form | Tablets |
| Route of Administration | Oral |
| Pharmacological Class | Glucocorticoid Corticosteroid |
| Therapeutic Category | Anti-inflammatory / Immunosuppressive |
| Primary Pharmacological Action | Modulation of inflammatory and immune responses |
| Standard | BP, where applicable to the approved specification |
| Product Type | Finished Pharmaceutical Dosage Form |
| Packaging | As per approved product specification |
| Labeling | As per approved product and destination-market requirements |
| Storage | As stated on approved product labeling |
| Shelf Life | As per approved product specification |
| Manufacturing Origin | India |
| Manufacturer/Supplier | Taj Pharma Ltd |
| Export Availability | Subject to applicable regulatory and commercial requirements |
Dexamethasone Tablets BP 0.5mg Side Effects
Like other corticosteroids, dexamethasone can cause adverse effects, particularly with higher doses, prolonged treatment, or repeated courses.
Potential adverse effects may include stomach irritation, increased appetite, weight changes, fluid retention, changes in blood glucose, mood or sleep changes, increased susceptibility to infection, and blood-pressure changes.
Longer-term corticosteroid treatment can be associated with more significant effects involving the bones, eyes, metabolism, cardiovascular system, gastrointestinal system, skin, and immune system.
The likelihood and severity of adverse effects depend on the dose, duration, individual patient characteristics, and underlying medical conditions.
Patients should contact their healthcare professional if they experience persistent or concerning symptoms.
Important Safety Information
Dexamethasone suppresses or modifies immune activity. Consequently, it can sometimes increase susceptibility to infections or mask signs of infection.
Patients should inform their healthcare professional if they have a current infection, recent exposure to certain infections, diabetes, hypertension, osteoporosis, gastrointestinal problems, glaucoma, or other significant medical conditions.
Patients should also disclose all prescription medicines, non-prescription medicines, and supplements they are taking because corticosteroids can interact with other treatments.
Pregnant or breastfeeding patients should discuss the use of dexamethasone with their healthcare professional before treatment.
Because corticosteroid treatment can affect the body’s own steroid production, prolonged treatment should generally not be stopped suddenly unless specifically directed by a healthcare professional.
Dexamethasone Tablets BP 0.5mg and Inflammatory Conditions
Inflammation is a protective biological response, but excessive or inappropriate inflammation can contribute to tissue damage and disease symptoms.
Dexamethasone reduces inflammatory signaling and immune activity, which is why it may be prescribed for selected corticosteroid-responsive inflammatory conditions.
The appropriate dose and treatment duration vary according to the disease and individual patient response. A 0.5mg tablet strength can be useful when a lower-strength oral dosage form is required, subject to the prescribing regimen and approved product labeling.
Dexamethasone Tablets BP 0.5mg and Autoimmune Conditions
Autoimmune diseases occur when the immune system reacts abnormally against the body’s own tissues. Corticosteroids such as dexamethasone can reduce excessive immune and inflammatory activity in selected circumstances.
However, corticosteroid therapy is not appropriate for every autoimmune condition or every patient. Treatment plans may involve other disease-modifying medicines, biologic therapies, or supportive treatments depending on the specific diagnosis.
Therefore, Dexamethasone Tablets BP 0.5mg should be used only for approved or clinically appropriate indications under professional supervision.
Dexamethasone Tablets BP 0.5mg in Oncology and Specialist Care
Dexamethasone has applications in selected oncology and specialist-care settings. Depending on the clinical context, corticosteroids may be used to help manage inflammatory symptoms, treatment-associated complications, cerebral edema, or other specific indications.
The use of dexamethasone in cancer care is highly dependent on the disease, treatment protocol, dosage regimen, and patient condition. It should therefore be administered according to specialist guidance and the relevant clinical protocol.
Pharmaceutical Export from India
India’s pharmaceutical sector serves a broad international customer base, making the country an important source of finished pharmaceutical formulations.
For international buyers, successful pharmaceutical procurement involves evaluating product quality, regulatory documentation, manufacturing capability, packaging, pricing, order requirements, logistics, and destination-country compliance.
Taj Pharma supports inquiries for Dexamethasone Tablets BP 0.5mg from eligible importers, distributors, pharmaceutical companies, and institutional buyers. Export arrangements remain subject to applicable pharmaceutical regulations and import requirements.
Contact Taj Pharma
If you are an importer, distributor, wholesaler, pharmaceutical company, healthcare procurement organization, or international buyer looking for Dexamethasone Tablets BP 0.5mg from India, contact Taj Pharma to discuss product specifications, commercial requirements, packaging, documentation, and export opportunities.
Mobile / WhatsApp Support:
+91-74-0000-9975
+91-74-0000-9976
Email:
info@tajpharma.com
tajgroup@tajpharma.com
For international inquiries, buyers are encouraged to specify the destination country, required strength, quantity, packaging preference, registration status, and documentation requirements so that the appropriate commercial and regulatory information can be evaluated.
Top 20 FAQs
1. What are Dexamethasone Tablets BP 0.5mg?
Dexamethasone Tablets BP 0.5mg are oral tablets containing 0.5mg dexamethasone, a potent glucocorticoid corticosteroid used for selected inflammatory, allergic, immune-mediated, and other corticosteroid-responsive conditions.
2. What is the active ingredient in Dexamethasone Tablets BP 0.5mg?
The active pharmaceutical ingredient is dexamethasone, supplied at a strength of 0.5mg per tablet according to the approved product specification.
3. What are Dexamethasone Tablets BP 0.5mg used for?
They may be prescribed for selected inflammatory, allergic, autoimmune, immune-mediated, hematological, neurological, and other corticosteroid-responsive conditions, depending on local approval and clinical requirements.
4. What does BP mean in Dexamethasone Tablets BP 0.5mg?
BP generally refers to the British Pharmacopoeia standard where the product is manufactured and tested according to an applicable BP specification.
5. Is dexamethasone an antibiotic?
No. Dexamethasone is a corticosteroid, not an antibiotic. It modifies inflammatory and immune responses rather than directly killing bacteria.
6. How does dexamethasone work?
Dexamethasone activates glucocorticoid receptors and modifies gene expression involved in inflammatory and immune processes, thereby reducing excessive inflammation and immune activity.
7. Can Dexamethasone Tablets BP 0.5mg be taken without a prescription?
Dexamethasone is a potent corticosteroid and should be used under appropriate medical supervision. It should not be self-medicated.
8. Should dexamethasone be taken with food?
Depending on the prescribed regimen, taking oral dexamethasone with food may help reduce stomach irritation. Patients should follow their healthcare professional’s instructions and the approved product information.
9. Can dexamethasone be stopped suddenly?
After prolonged or repeated corticosteroid treatment, stopping suddenly can be unsafe because the body may need time to restore normal adrenal function. Do not discontinue long-term treatment without medical advice.
10. What are common side effects of dexamethasone?
Potential adverse effects include stomach irritation, increased appetite, weight changes, fluid retention, mood or sleep changes, increased blood glucose, and increased susceptibility to infections.
11. Can dexamethasone affect blood sugar?
Yes. Corticosteroids can increase blood glucose levels. People with diabetes or those at risk of diabetes should discuss corticosteroid therapy with their healthcare professional.
12. Can dexamethasone increase the risk of infection?
Yes. Because dexamethasone suppresses immune responses, it can increase susceptibility to certain infections or make existing infection symptoms less obvious.
13. Can pregnant women take Dexamethasone Tablets BP 0.5mg?
Pregnancy requires individualized medical assessment. A pregnant patient should use dexamethasone only when specifically recommended by a qualified healthcare professional.
14. Can breastfeeding mothers take dexamethasone?
Breastfeeding patients should discuss dexamethasone treatment with their healthcare professional, particularly when higher doses or prolonged treatment are involved.
15. Who manufactures Dexamethasone Tablets BP 0.5mg in India?
Taj Pharma Ltd, based in Vapi, Gujarat, India, offers pharmaceutical manufacturing, supply, and export services for Dexamethasone Tablets BP 0.5mg, subject to applicable product and market requirements.
16. Can Taj Pharma supply Dexamethasone Tablets BP 0.5mg for export?
Taj Pharma can handle international supply inquiries for eligible pharmaceutical buyers, subject to destination-country regulations, product registration, import requirements, and commercial feasibility.
17. Can custom packaging be arranged?
Custom packaging and labeling may be considered depending on the product registration, buyer requirements, approved artwork, and applicable regulations in the destination market.
18. What documents can pharmaceutical buyers request?
Depending on the market, buyers may require Certificate of Analysis, product specifications, manufacturing documentation, GMP-related documents, CPP/COPP, stability information, and regulatory dossier materials.
19. Does Taj Pharma provide WHO-GMP certification?
The phrase WHO-GMP manufacturer India should be used only where a current, applicable certification supports that claim. Certification scope and validity should be verified for the specific manufacturing facility and relevant operations.
20. How can international buyers contact Taj Pharma?
Buyers can contact Taj Pharma through info@tajpharma.com, tajgroup@tajpharma.com, +91-22-2637 4592, +91-22-2637 4593, +91-84484 44095, or the listed WhatsApp numbers for pharmaceutical supply inquiries.


















